Details of the Drug

General Information of Drug (ID: DMEXZQ2)

Drug Name

QPX7728

Synonyms

Xeruborbactam; Xeruborbactam [INN]; 2170834-63-4; DE79L822UY; UNII-DE79L822UY; CHEMBL4633785; Benzo(E)cycloprop(C)(1,2)oxaborin-4-carboxylic acid, 5-fluoro-1,1a,2,7B-tetrahydro-2-hydroxy-, (1aR,7bS)-; QPX7728; EX-A7712; QPX-7728; BDBM50541448; AKOS040735994; PD193971; HY-136069; CS-0119486

Indication

Disease Entry	ICD 11	Status	REF
Bacterial infection	1A00-1C4Z	Phase 1	[1]

Drug Type

Small molecule

Structure

3D MOL is unavailable

2D MOL

Chemical Identifiers

Formula: C10H8BFO4
Canonical SMILES: B1(C2CC2C3=C(O1)C(=C(C=C3)F)C(=O)O)O
InChI: InChI=1S/C10H8BFO4/c12-7-2-1-4-5-3-6(5)11(15)16-9(4)8(7)10(13)14/h1-2,5-6,15H,3H2,(H,13,14)/t5-,6-/m1/s1
InChIKey: KOHUFVUIYUCFNG-PHDIDXHHSA-N

Cross-matching ID

PubChem CID: 140830474
ChEBI ID: CHEMBL4633785
TTD ID: DMQ86J

Drug-Molecule Activity Atlas (DMA)^NEW

Click to Jump to the Detailed DMA Information of This Drug

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Staphylococcus Beta-lactamase (Stap-coc blaZ)	TTHI19T	BLAC_STAAU	Inhibitor	[2]

Molecular Interaction Atlas (MIA)

MIA Detail

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT05072444) A Phase 1, Randomized, Double-Blind, Single-Dose, Drug-Drug Interaction Study to Determine the Impact of Co-administration of QPX7728 on the Pharmacokinetics of QPX2014 in Healthy Adult Subjects. U.S.National Institutes of Health.
2	QPX7728, An Ultra-Broad-Spectrum B-Lactamase Inhibitor for Intravenous and Oral Therapy: Overview of Biochemical and Microbiological Characteristics. Front Microbiol. 2021 Jul 5;12:697180.